Perform a follow-up prostate biopsy even when the first is negative

October 1997
Modern Medicine;Oct97, Vol. 65 Issue 10, p10
Focuses on the study recommending a second transrectal ultrasound-guided needle biopsy of the prostate when the first biopsy is negative. Target on men with high levels of prostate-specific antigen; Failure to identify small cancers during the first biopsy.


Related Articles

  • Managing Patients Following a Negative Prostate Biopsy.  // Renal & Urology News;Feb2011, Vol. 10 Issue 2, p23 

    The article addresses several issues affecting the scenario posed by patients who have undergone repeat biopsy for prostate cancer in the U.S. It stresses that urologists need to consider several factors when deciding a repeat biopsy which is more likely to indicate cancer because the previous...

  • PROSTATE CANCER DIAGNOSTICS WITH BIOPSY MATERIAL. Fedorina, T. A.; Poletaeva, S. V. // Saratov Journal of Medical Scientific Research / Saratovskii Nau;Oct-Dec2013, Vol. 9 Issue 4, p632 

    The aim of the article is to study the potential importance of specific location of biopsy of prostate cancer. Material and methods. Histological material from 700 patients has been examinated. 580 specimen of radical prostatectomy were examined. TRUS-guided 12-cores biopsy has been performed in...

  • Histopathological lesions in transrectal ultrasound guided biopsies of prostate in patients with raised serum prostate specific antigen: A preliminary report. Barakzai, Muhammed Abrar; Mubarak, Muhammed; Kazi, Javed Iqbal // Nephro-Urology Monthly;Jun2011, Vol. 3 Issue 3, p186 

    Background: Transrectal ultrasound (TRUS)-guided needle biopsies of prostate are considered the gold standard for the diagnosis of the prostatic cancer. Currently, there is no information on the spectrum of pathological lesions in TRUS biopsies of prostate in men from Pakistan. Objectives: To...

  • Urologic imaging for localized prostate cancer in 2007. Loch, Tillmann // World Journal of Urology;Apr2007, Vol. 25 Issue 2, p121 

    Increasing numbers of systematic random biopsies have virtually replaced urologic imaging as a detection and staging tool in prostate cancer. TRUS as the most commonly utilized urologic imaging is now mainly utilized to guide the biopsy needle into the correct anatomical or topographic region of...

  • Best Practice in Diagnostic Immunohistochemistry. Paner, Gladell P.; Luthringer, Daniel J.; Amin, Mahul B. // Archives of Pathology & Laboratory Medicine;Sep2008, Vol. 132 Issue 9, p1388 

    Context.—The unrelenting challenge encountered when differentiating limited-volume prostate carcinoma and sometimes subtle variants from its many morphologic mimics has increased the use of ancillary immunohistochemistry in routine prostate needle biopsies. The availability of prostate...

  • Prostate Cancer Detection Rate and the Importance of Premalignant Lesion in Rebiopsy.  // Medicinski Arhiv;2011, Vol. 65 Issue 2, p109 

    No abstract available.

  • Specimen Orientation by Marking the Peripheral End: (Potential) Clinical Advantages in Prostate Biopsy. Galosi, Andrea Benedetto; Muzzonigro, Giovanni; Lacetera, Vito; Mazzucchelli, Roberta // Prostate Cancer (20903111);2011, p1 

    The aim of this paper is to identify advantages that could be obtained by orientation of the biopsy specimen using the marking technique. We reviewed our experience (4,500 cases) and the published literature. The peripheral (proximal) end of the fresh specimen is marked with ink soon after...

  • Systematic Analysis of Transrectal Prostate Biopsies Using an Ink Method and Specific Histopathologic Protocol: AProspective Study. Parada, David; Calvo, Nahum; Pe˜na, Karla; Morente, Vanesa; Hernandez, Pilar; Riu, Francesc // Prostate Cancer (20903111);2011, p1 

    Background. Transrectal prostate biopsy is the standard protocol for the screening for prostate cancer. It helps to locate prostatic adenocarcinoma and plan treatment. However, the increasing number of prostate biopsies leads to considerably greater costs for the pathology laboratories. In this...

  • Beyond Diagnosis: Evolving Prostate Biopsy in the Era of Focal Therapy. Dominguez-Escrig, J. L.; McCracken, S. R. C.; Greene, D. // Prostate Cancer (20903111);2011, p1 

    Despite decades of use as the "gold standard" in the detection of prostate cancer, the optimal biopsy regimen is still not universally agreed upon. While important aspects such as the need for laterally placed biopsies and the importance of apical cancer are known, repeated studies have shown...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics